Imaginostics has received a letter of support from Siemens Healthineers regarding exploratory discussions regarding potential collaboration in quantitative MRI and imaging biomarkers.
The two firms will discuss potential technical and commercial pathways for Imaginostics' work-in-progress ImagiView and ImagiSight platforms for vascular imaging analysis and their potential applications for Siemens Healthineers Magnetom MRI systems, Imaginostics said.
